daratumumab
janssen
['improve ', 'darzalex', 'janssen']
 #oncology #portfolio grew @ ~20% cagr in the last five years driven primarily by darzalex. upcoming products will further improve jnj's market share in oncology by 2028 #whatsnext @ #esmo22 follow us 
A healthcare-focused strategy consulting firm, providing bench-to-bedside decision support to pharmaceutical, biotech, and medical device companies